BioPlus Acquisition Number Of Shares Shorted vs. Short Ratio

BIOSDelisted Stock  USD 10.73  0.00  0.00%   
Considering BioPlus Acquisition's profitability and operating efficiency indicators, BioPlus Acquisition Corp may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess BioPlus Acquisition's ability to earn profits and add value for shareholders.
For BioPlus Acquisition profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioPlus Acquisition to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioPlus Acquisition Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioPlus Acquisition's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioPlus Acquisition Corp over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Please note, there is a significant difference between BioPlus Acquisition's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioPlus Acquisition is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioPlus Acquisition's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioPlus Acquisition Corp Short Ratio vs. Number Of Shares Shorted Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BioPlus Acquisition's current stock value. Our valuation model uses many indicators to compare BioPlus Acquisition value to that of its competitors to determine the firm's financial worth.
BioPlus Acquisition Corp is rated below average in number of shares shorted category among its peers. It is rated below average in short ratio category among its peers . The ratio of Number Of Shares Shorted to Short Ratio for BioPlus Acquisition Corp is about  54,667 . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioPlus Acquisition by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

BioPlus Short Ratio vs. Number Of Shares Shorted

Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

BioPlus Acquisition

Shares Shorted

 = 

Shorted by Public

+

by Institutions

 = 
1.64 K
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

BioPlus Acquisition

Short Ratio

 = 

Short Interest

Average Trading Volume

 = 
0.03 X
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.

BioPlus Short Ratio Comparison

BioPlus Acquisition is currently under evaluation in short ratio category among its peers.

BioPlus Acquisition Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BioPlus Acquisition, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioPlus Acquisition will eventually generate negative long term returns. The profitability progress is the general direction of BioPlus Acquisition's change in net profit over the period of time. It can combine multiple indicators of BioPlus Acquisition, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioPlus Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange.

BioPlus Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BioPlus Acquisition. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioPlus Acquisition position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioPlus Acquisition's important profitability drivers and their relationship over time.

Use BioPlus Acquisition in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioPlus Acquisition position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioPlus Acquisition will appreciate offsetting losses from the drop in the long position's value.

BioPlus Acquisition Pair Trading

BioPlus Acquisition Corp Pair Trading Analysis

The ability to find closely correlated positions to BioPlus Acquisition could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioPlus Acquisition when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioPlus Acquisition - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioPlus Acquisition Corp to buy it.
The correlation of BioPlus Acquisition is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioPlus Acquisition moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioPlus Acquisition Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioPlus Acquisition can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BioPlus Acquisition position

In addition to having BioPlus Acquisition in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run USD Crypto Fund Thematic Idea Now

USD Crypto Fund
USD Crypto Fund Theme
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in BioPlus Stock

If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years